Zigakibart treatment continues to demonstrate rapid and sustained reductions in mechanistic biomarkers, including IgA and Gd-IgA1 levels, which correspond to clinically meaningful proteinuria reductions in patients with IgAN across Cohorts… Read More
Novartis to acquire Chinook for $40 per share in cash, with potential to receive up to an additional $4 per share in cash through contingent value rights, for a total equity value of up to approximately $3.5… Read More
To help you identify and mitigate risk, Mary Buttery, KC, Teresa Tomchak, and Emily MacKinnon from the Osler Vancouver Litigation team will address topics including alternative dispute resolution mechanisms and… Read More
VANCOUVER, BC — People in B.C. will benefit from sustained cutting-edge research, especially focused on improving health care, as the Province provides $20 million over two years to the Michael… Read More
VANCOUVER, BC — PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE:MDMA)(OTC:PMBHF), a biotechnology company focused on the research, development, and manufacturing of MDXX class molecules (including MDMA), is pleased to report that the… Read More
